Thus far, we demonstrated that modulating the expression of either ASCL1 or NDRG1 in PN CSCs promotes the transition from one GBM subgroup to another, thus significantly contributing to the shaping of the transcriptional subgrouping of GBM. The gene discussed is NDRG1; the disease is glioblastoma.